1. Home
  2. KYTX vs FVCB Comparison

KYTX vs FVCB Comparison

Compare KYTX & FVCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYTX
  • FVCB
  • Stock Information
  • Founded
  • KYTX 2018
  • FVCB 2007
  • Country
  • KYTX United States
  • FVCB United States
  • Employees
  • KYTX N/A
  • FVCB N/A
  • Industry
  • KYTX
  • FVCB Major Banks
  • Sector
  • KYTX
  • FVCB Finance
  • Exchange
  • KYTX NYSE
  • FVCB Nasdaq
  • Market Cap
  • KYTX 150.0M
  • FVCB 204.0M
  • IPO Year
  • KYTX 2024
  • FVCB N/A
  • Fundamental
  • Price
  • KYTX $2.81
  • FVCB $12.69
  • Analyst Decision
  • KYTX Strong Buy
  • FVCB
  • Analyst Count
  • KYTX 5
  • FVCB 0
  • Target Price
  • KYTX $19.00
  • FVCB N/A
  • AVG Volume (30 Days)
  • KYTX 627.6K
  • FVCB 57.4K
  • Earning Date
  • KYTX 08-11-2025
  • FVCB 07-24-2025
  • Dividend Yield
  • KYTX N/A
  • FVCB N/A
  • EPS Growth
  • KYTX N/A
  • FVCB 311.46
  • EPS
  • KYTX N/A
  • FVCB 1.03
  • Revenue
  • KYTX N/A
  • FVCB $60,453,000.00
  • Revenue This Year
  • KYTX N/A
  • FVCB $8.48
  • Revenue Next Year
  • KYTX N/A
  • FVCB $7.88
  • P/E Ratio
  • KYTX N/A
  • FVCB $12.33
  • Revenue Growth
  • KYTX N/A
  • FVCB 34.53
  • 52 Week Low
  • KYTX $1.78
  • FVCB $9.49
  • 52 Week High
  • KYTX $11.40
  • FVCB $14.50
  • Technical
  • Relative Strength Index (RSI)
  • KYTX 46.73
  • FVCB 74.50
  • Support Level
  • KYTX $2.71
  • FVCB $11.73
  • Resistance Level
  • KYTX $3.75
  • FVCB $12.07
  • Average True Range (ATR)
  • KYTX 0.31
  • FVCB 0.35
  • MACD
  • KYTX -0.08
  • FVCB 0.10
  • Stochastic Oscillator
  • KYTX 9.62
  • FVCB 95.12

About KYTX KYVERNA THERAPEUTICS INC

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

About FVCB FVCBankcorp Inc.

FVCBankcorp Inc is a registered bank holding company. It operates through the sole subsidiary, FVCbank which is a community-oriented, locally-owned, and managed commercial bank. It offers commercial banking services to small and medium-sized businesses, professionals, non-profit organizations and associations, and investors. It also provides retail banking services to accommodate the individual needs of both corporate customers as well as the communities it serves. The bank provides other facilities such as online banking, mobile banking, remote deposit service, and lending products, among others. Its primary source of revenue is the net interest income.

Share on Social Networks: